Your browser doesn't support javascript.
loading
Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies.
Meier, Edward; Narvekar, Abhijit; Iyer, Ganesh R; DuBiner, Harvey B; Vutikullird, Apinya; Wirta, David; Sall, Kenneth.
Affiliation
  • Meier E; Apex Eye, Mason, OH.
  • Narvekar A; Alcon Research Ltd., Fort Worth, TX.
  • Iyer GR; Alcon Research Ltd., Fort Worth, TX.
  • DuBiner HB; Clayton Eye Center, Morrow, GA.
  • Vutikullird A; WCCT Global, Cypress.
  • Wirta D; Eye Research Foundation, Newport Beach.
  • Sall K; Sall Eye Research Medical Center, Artesia, CA, USA.
Clin Ophthalmol ; 11: 669-681, 2017.
Article in En | MEDLINE | ID: mdl-28435218
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Clin Ophthalmol Year: 2017 Document type: Article Country of publication: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Clin Ophthalmol Year: 2017 Document type: Article Country of publication: New Zealand